The equivalent cytotoxicity found between all three pancreatic cancer lines using a control ADC targeting EpCAM (Figure 4B) demonstrates that the differences observed among the cell lines with the anti-SAS1B ADC are due to target density differences rather than inherent differences in how each cell line processes and responds to an ADC. Here, EPCAM is linked to familial pancreatic carcinoma.